US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

IMUX

Immunic (IMUX)

Immunic Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IMUX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/06	19 : 30	PR Newswire (US)	Immunic to Participate in Investor and Scientific Conferences in May	NASDAQ:IMUX	Immunic Inc
2024/05/01	19 : 30	PR Newswire (US)	Immunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update	NASDAQ:IMUX	Immunic Inc
2024/04/30	19 : 30	PR Newswire (US)	Immunic Announces Publication of Extended Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis in the Peer Reviewed Journal, Neurology® Neuroimmunology & Neuroinflammation	NASDAQ:IMUX	Immunic Inc
2024/04/04	19 : 30	PR Newswire (US)	Immunic to Host MS R&D Day and Participate in Investor Conferences in April	NASDAQ:IMUX	Immunic Inc
2024/03/20	19 : 30	PR Newswire (US)	Immunic Receives Notice of Allowance for Composition-of-Matter Patent of a Specific Polymorph of Vidofludimus Calcium in the United States	NASDAQ:IMUX	Immunic Inc
2024/03/09	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMUX	Immunic Inc
2024/03/07	20 : 30	PR Newswire (US)	Immunic to Participate in Investor and Scientific Conferences in March	NASDAQ:IMUX	Immunic Inc
2024/03/07	11 : 52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMUX	Immunic Inc
2024/03/07	11 : 51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMUX	Immunic Inc
2024/03/07	11 : 51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMUX	Immunic Inc
2024/03/07	11 : 50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMUX	Immunic Inc
2024/03/07	11 : 50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMUX	Immunic Inc
2024/03/07	11 : 50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMUX	Immunic Inc
2024/02/29	20 : 30	PR Newswire (US)	Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024	NASDAQ:IMUX	Immunic Inc
2024/02/22	20 : 38	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:IMUX	Immunic Inc
2024/02/22	20 : 35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMUX	Immunic Inc
2024/02/22	20 : 30	PR Newswire (US)	Immunic, Inc. Reports Year End 2023 Financial Results and Provides Corporate Update	NASDAQ:IMUX	Immunic Inc
2024/02/15	20 : 30	PR Newswire (US)	Immunic, Inc. to Announce Financial Results for the Year Ended December 31, 2023, and Provide Corporate Update	NASDAQ:IMUX	Immunic Inc
2024/02/15	06 : 05	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:IMUX	Immunic Inc
2024/02/14	22 : 47	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:IMUX	Immunic Inc
2024/02/14	21 : 55	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:IMUX	Immunic Inc
2024/02/14	06 : 36	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:IMUX	Immunic Inc
2024/02/05	22 : 30	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:IMUX	Immunic Inc
2024/02/01	20 : 30	PR Newswire (US)	Immunic to Participate in Investor and Scientific Conferences in February	NASDAQ:IMUX	Immunic Inc
2024/01/25	07 : 05	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:IMUX	Immunic Inc
2024/01/20	06 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMUX	Immunic Inc
2024/01/20	06 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMUX	Immunic Inc
2024/01/20	06 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMUX	Immunic Inc
2024/01/20	06 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMUX	Immunic Inc
2024/01/20	06 : 05	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:IMUX	Immunic Inc

Showing the most relevant articles for your search:NASDAQ:IMUX

1 2 3 4 5 6 7 8 9 10 次へ >>

BNP Paribas (QX)

US Dollar vs Euro

Energy Select Sector SPDR

Health Care Select Sector

Invesco QQQ Trust Series 1

Deutsche Telekom (QX)

Financial Select Sector

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約